NPNatalia Yu. Pylaeva

Natalia Yu. Pylaeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalia Yu. Pylaeva has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of the relationship of LDH/AST ratio with the probability of manifestation and duration of HELLP syndrome (multicenter longitudinal analytical clinical trial)

    by N. Yu. Pylaeva, D. N. Protsenko, Y. M. Shifman, O. V. Ignatenko, A. V. Kulikov, Yu. S. Raspopin, O. V. Ryazanova, N. V. Lishchenko, A. V. Pylaev, E. V. Sadovaya, et al.

    Introduction. HELLP syndrome is a life-threatening complication of preeclampsia with high rates of maternal and perinatal morbidity, which necessitates the development of reliable prognostic markers of its manifestation and duration. The article presents the results of a multicenter retrospective analytical clinical trial «HELLP-RU», dedicated to assessing the prognostic significance of the ratio of lactate dehydrogenase to aspartate aminotransferase (LDH/AST) in pregnant women with preeclampsia.The objective was to evaluate the association between the lactate dehydrogenase to aspartate aminotransferase ratio (LDH/AST) and both the likelihood of HELLP syndrome manifestation and the duration of its clinical course. Materials and methods . This study included 139 female patientы diagnosed with complete or partial HELLP syndrome (2018–2022, 16 clinical centers). Laboratory and clinical data were analyzed at three predefined time points: upon hospital admission, immediately prior to delivery, and during the postpartum period. Temporal changes in the LDH/AST ratio were examined in relation to timing of disease onset and overall disease duration. Results . The distribution of complete and partial forms of HELLP syndrome varied across the stages of clinical observation. Dynamic analysis of the LDH/AST ratio demonstrated statistically significant intergroup differences. Persistently low LDH/AST ratios (< 5) were associated with a prolonged clinical course of HELLP syndrome, whereas higher ratios (> 10) correlated with its short-term course. Notably, a decline in the LDH/AST ratio in the absence of overt clinical deterioration preceded clinical manifestation of HELLP syndrome. Conclusions . The study revealed that the LDH/AST ratio is an accessible prognostic marker of the manifestation and duration of HELLP syndrome, which is important for timely clinical management and reducing the incidence of adverse outcomes.

  • Open Access

    The effect of the use of virtual reality technology on the course of the perioperative period during cesarean section

    by O. V. Ryazanova, S. M. Makishev, G. V. Grinenko, N. Yu. Pylaeva, K. I. Korolev, S. A. Kolominchuk, М. Д. Нагульманова, A. A. Ryazanova

    Introduction. Cesarean section is associated with a significant level of emotional stress. Given the inability to use most anxiolytic drugs in obstetrics, alternative methods for stabilizing the psycho-emotional state of patients are required. One possible option is virtual reality technology. The objective was to evaluate the impact of virtual reality technology on perinatal anxiety and pain intensity during elective cesarean section.Materials and Methods. A prospective randomized controlled trial was conducted with 62 patients. The patients were divided into two groups: the control group (n = 30) and the main group (n = 32). In the control group, standard preoperative preparation was performed, while in the main group, virtual reality technology was additionally used. Anxiety levels were assessed using the PASS-R scale, and pain intensity was evaluated using the visual analog scale (VAS). Additionally, blood pressure and heart rate indicators were analyzed. Results. Compared to the control group, the use of virtual reality technology resulted in a significant reduction in anxiety levels 6 hours after surgery (11.2 ± 4.9 vs. 17.4 ± 5.8 points, p < 0.05) and a decrease in pain intensity during fetal extraction (2.5 ± 1.3 vs. 4.0 ± 1.3 points, p = 0.0089). The main group also showed lower blood pressure and heart rate indicators compared to the control group at all stages of the surgical intervention (p < 0.05).Conclusion. The use of virtual reality technology before and during elective cesarean section under spinal anesthesia may be an effective method for reducing anxiety, stress, and pain during surgery and in the postoperative period, as well as for improving the psychological state of patients.


  • Open Access

    Possibilities of Predicting the Manifestation of HELLP Syndrome

    by E. M. Shifman, N. Yu. Pylaeva, V. V. Gulyaev, A. V. Kulikov, A. V. Pylaev, E. N. Kazinina, E. N. Prochan

    Introduction. Despite the use of modern principles of treatment of severe preeclampsia, mortality rates for mother and newborn in the development of life-threatening complication of preeclampsia, such as HELLP syndrome, remains high. The introduction of accurate models of early diagnosis and prediction of the probability of manifestation and severity of the HELLP syndrome into everyday medical practice will improve the safety of delivery of pregnant women with severe preeclampsia.The aim of the study is to determine the current state of the issue and systematize current data on methods of predicting the probability of HELLP syndrome manifestation.Materials and methods. An analytical review of the literature. A qualitative analysis of clinical trials and reviews on prediction of HELLP syndrome was conducted using the following data sources: PubMed and Google Scholar. The search was carried out in Russian and English, using the keywords “predictors”, or “prediction”, and “HELLP syndrome”. The date of the last search query is 22 March 2024.Results. Anamnestic data and initial characteristics of patients with HELLP syndrome were analyzed.Discussion. The analytical review included publications devoted to the study of the influence of predictive capabilities of potential biochemical markers, clinical and anamnestic signs and instrumental examination data on the probability of HELLP syndrome development.Conclusion. Adequate prediction of the manifestation of HELLP syndrome is possible on the basis of a comprehensive analysis of all identified factors, allowing the identification of effective prognostic models to improve maternal and fetal outcomes in pregnant women with severe preeclampsia.


  • Open Access

    Outcomes of Placental Abruption Depending on Severity of Pre-Eclampsia: A Multicentre Cohort Observational Retrospective Study

    by I. S. Rudakova, E. M. Shifman, G. P. Tikhova, M. A. Andriyakhova, N. V. Artymuk, V. A. Bagiyants, F. R. Barakaeva, S. V. Barinov, N. A. Barkovskaya, A. A. Belinina, et al.

    Aim. Placental abruption is a severe complication of pregnancy, which is often accompanied by pre-eclampsia and early delivery. Here we aimed to study maternal and neonatal outcomes in patients with placental abruption depending on the severity of pre-eclampsia.Materials and Methods. The study included 509 patients with placental abruption and pre-eclampsia from 22 medical centers in 16 regions of the Russian Federation, which were divided into two groups: patients with placental abruption and severe pre-eclampsia (n = 369) and patients with placental abruption and moderate pre-eclampsia (n = 140).Results. Regardless of the severity of pre-eclampsia, average term of placental abruption was 34 weeks of pregnancy. Among the adverse maternal outcomes in patients with placental abruption and severe pre-eclampsia were coagulopathy (OR = 5.01; 95% CI = 1.17–21.46) and near miss proportion (OR = 2.95; 95% CI =1.22 –7.08) which were significantly more common as compared to a moderate pre-eclampsia. Neonatal outcomes were accompanied by a high perinatal mortality (12.8%) and neonatal morbidity due to a high prevalence of premature birth (65%), asphyxia (64%), and small for gestational age (40%). Groups with severe and moderate pre-eclampsia had no statistically significant differences in neonatal outcomes, excepting congenital malformations which were found less frequently (OR = 0.32; 95% CI 0.13–0.79) in severe pre-eclampsia.Conclusion. Severity of pre-eclampsia did not affect neonatal outcomes in women with placental abruption. Maternal outcomes were significantly worse in patients with severe pre-eclampsia in comparison with those with moderate pre-eclampsia.


  • Open Access

    Septic shock in obstetrics: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists”

    by Александр Вениаминович Куликов, E. M. Shifman, D. N. Protsenko, A. M. Ovezov, А. М. Роненсон, Yu. S. Raspopin, N. V. Artymuk, T. E. Belokrynitskaya, K. N. Zolotukhin, A. V. Shchegolev, et al.

    The article reflects the main provisions of the clinical guidelines on septic shock in obstetrics, approved by the All-Russian public organization “Federation of Anesthesiologists-Resuscitators” in 2022. The relevance of the problem is associated with high mortality and morbidity rates from sepsis and septic shock in obstetrics. The main issues of etiology, pathogenesis, clinical picture, methods of laboratory and instrumental diagnostics, features of using the qSOFA, SOFA, MOEWS, SOS, MEWC, IMEWS scales for sepsis verification are consistently presented. The article presents the starting intensive therapy (the first 6–12 hours) of the treatment of septic shock in obstetrics, taking into account the characteristics of the pregnant woman's body. The strategy of prescribing vasopressors (norepinephrine, phenylephrine, epinephrine), inotropic drugs (dobutamine) is described, antibiotics and optimal antibiotic therapy regimens, features of infusion and adjuvant therapy are presented. The issues of surgical treatment of the focus of infection and indications for hysterectomy, as well as the organization of medical care and rehabilitation of patients with sepsis and septic shock were discussed. The basic principles of prevention of sepsis and septic shock in obstetrics are described. The criteria for the quality of medical care for patients with septic shock and the algorithms of doctor's actions in the diagnosis and intensive care of patients with septic shock in obstetrics are presented. В статье отражены основные положения клинических рекомендаций по септическому шоку в акушерстве, утвержденных Общероссийской общественной организацией «Федерация анестезиологов и реаниматологов» в 2022 г. Актуальность проблемы связана с высокими показателями летальности и заболеваемости от сепсиса и септического шока в акушерстве. Последовательно представлены основные вопросы этиологии, патогенеза, клинической картины, методов лабораторной и инструментальной диагностики, особенности применения шкал qSOFA, SOFA, MOEWS, SOS, MEWC, IMEWS для верификации сепсиса. В статье представлена стартовая интенсивная терапия (первые 6–12 ч) лечения септического шока в акушерстве с учетом особенностей организма беременной женщины. Описана стратегия назначения вазопрессоров (норэпинефрин, фенилэфрин, эпинефрин), инотропных препаратов (добутамин), представлены антибиотики и оптимальные схемы антибактериальной терапии, особенности инфузионной и адъювантной терапии. Обсуждены вопросы хирургического лечения очага инфекции и показания к гистерэктомии, а также организация медицинской помощи и реабилитация пациенток, перенесших сепсис и септический шок. Описаны основные принципы профилактики развития сепсиса и септического шока в акушерстве. Представлены критерии качества оказания медицинской помощи пациенткам с септическим шоком и алгоритмы действий врача при диагностике и интенсивной терапии пациенток с септическим шоком в акушерстве.


  • Hypertensive disorders in pregnancy as a risk factor of premature placental abruption: a systematic review and meta-analysis

    by I.S. Rudakova, E.M. Shifman, G.P. Tikhova, N.YU. Pylaeva

    Background. Hypertensive disorders in pregnancy are often cited as a significant risk for placental abruption. Objective. To study the effect of hypertensive disorders during pregnancy on the risk of premature placental abruption. Material and methods. Searching for literature data was performed in the PubMed, Google Scholar and Cochrane databases. We analyzed the effect of chronic hypertension and pregnancy-induced hypertension (including preeclampsia, gestational hypertension and eclampsia) on placental abruption. Results. The meta-analysis included 17 studies with a total of 30.184.624 patients. Hypertensive disorders in pregnancy increase the risk of premature placental abruption by almost 3 times (OR 2.79; 95% CI 2.37-3.27). In case of chronic hypertension only, the probability of placental abruption increases by about 2 times (OR 2.22; 95% CI 1.67-2.96). Conclusion. Hypertensive disorders in pregnancy are a significant risk of placental abruption.


  • Anesthesia and intensive therapy in postpartum uterine inversion

    by A.V. Kulikov, E.M. Shifman, D.N. Protsenko, I.B. Zabolotskikh, A.M. Ovezov, N.V. Artymuk, T.E. Belokrinitskaya, A.M. Ronenson, A.A. Matkovskiy, Yu.S. Raspopin, et al.

    The authors present the guidelines for anesthesia and intensive care in postpartum uterine inversion. Diagnosis, assessment of severity, anesthesia options, conservative and surgical methods of correction, as well as intensive therapy of massive blood loss were discussed. The authors present the algorithms of medical care for postpartum uterine eversion and intensive care of massive blood loss. The criteria for the quality of medical care in maternity patients with postpartum uterine inversion are discussed.

  • Safety of terlipressin in prevention of postpartum hemorrhage in pregnant women with hypertensive disorders during pregnancy: a multiple-center cohort study

    by Yu.S. Raspopin, N.YU. Pylaeva, E.M. Shifman, A.A. Belinina, I.V. Molchanova

    В наших ранних сообщениях показано, что профилактическое применение терлипрессина позволяет снизить объем кровопотери при операции кесарева сечения (КС). Учитывая, что препарат является мощным вазопрессором, остается открытым вопрос безопасности его местного применения у женщин с гипертензивными расстройствами во время беременности. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить безопасность местного применения терлипрессина у беременных с гипертензивными расстройствами с целью профилактики послеродовых кровотечений при операции КС. МАТЕРИАЛ И МЕТОДЫ Обследовано 110 беременных женщин с гипертензивными расстройствами во время беременности и высокими факторами риска развития кровотечения. Женщины группы контроля (n=49) получали стандартную терапию согласно клиническим рекомендациям. У женщин группы исследования (n=61) стандартная профилактика дополнена введением терлипрессина в толщу миометрия. Проведена оценка системной гемодинамики, объема кровопотери, необходимости введения утеротоников второй линии и применения дополнительных методов хирургического гемостаза. Изучены осложнения, аллергические и побочные эффекты, связанные с применением терлипрессина. РЕЗУЛЬТАТЫ Сравнение показателей неинвазивной гемодинамики в абсолютных числах не показало статистически значимой разницы у женщин изучаемых групп на этапах операции и послеоперационного периода. При оценке дельт показателей гемодинамики отмечено снижение уровня среднего артериального давления на этапе послеоперационного наблюдения у пациенток как исследуемой группы, так и группы контроля — на 12 и 18% соответственно (pp=0,009) и среднего артериального давления (p=0,054) отмечено только в раннем послеоперационном периоде. Средние значения шокового индекса в группах статистически значимо не различались. Изменения шокового индекса установлены только у пациенток подгруппы с кровопотерей 1000 мл группы исследования: рост составил более 60%, тогда как у женщин группы контроля — не более 40%. Частота гистерэктомий у пациенток группы контроля была в 4,3 раза выше, чем у женщин группы исследования. ЗАКЛЮЧЕНИЕ Введение терлипрессина в толщу миометрия не вызывает изменения системной гемодинамики у пациенток с гипертензивными расстройствами во время беременности. На фоне применения препарата не было побочных и нежелательных реакций.


  • Diagnosis and intensive therapy of disseminated intravascular coagulation syndrome in massive blood loss in obstetrics (guidelines)

    by A.V. Kulikov, E.M. Shifman, D.N. Protsenko, I.B. Zabolotskikh, A.M. Ovezov, E.V. Roitman, N.V. Artymuk, A.A. Astakhov, T.E. Belokrinitskaya, A.M. Ronenson, et al.

    Статья представляет методические рекомендации по диагностике и интенсивной терапии ДВС-синдрома при массивной кровопотере в акушерстве. Рассмотрены вопросы клинической, лабораторной и инструментальной диагностики ДВС-синдрома при массивной кровопотере в акушерстве, применения аллогенных компонентов крови (эритроциты, плазма, криопреципитат, тромбоциты) и факторов свертывания крови (фактор VIIa, концентрат факторов протромбинового комплекса). Представлены критерии качества оказания медицинской помощи беременным женщинам, роженицам и родильницам с ДВС-синдромом при массивной кровопотере.